Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. 2008

Montserrat Ferrer, and José Francisco Suárez, and Ferran Guedea, and Pablo Fernández, and Víctor Macías, and Alfonso Mariño, and Asunción Hervas, and Ismael Herruzo, and María José Ortiz, and Humberto Villavicencio, and Jordi Craven-Bratle, and Olatz Garin, and Ferran Aguiló, and
Unidad de Investigación en Servicios Sanitarios, IMIM-Hospital del Mar, Barcelona, Spain. mferrer@imim.es

OBJECTIVE To compare treatment impact on health-related quality of life (HRQL) in patients with localized prostate cancer, from before treatment to 2 years after the intervention. METHODS This was a longitudinal, prospective study of 614 patients with localized prostate cancer treated with radical prostatectomy (134), three-dimensional external conformal radiotherapy (205), and brachytherapy (275). The HRQL questionnaires administered before and after treatment (months 1, 3, 6, 12, and 24) were the Medical Outcomes Study 36-Item Short Form, the Functional Assessment of Cancer Therapy (General and Prostate Specific), the Expanded Prostate Cancer Index Composite (EPIC), and the American Urological Association Symptom Index. Differences between groups were tested by analysis of variance and within-group changes by univariate repeated-measures analysis of variance. Generalized estimating equations (GEE) models were constructed to assess between-group differences in HRQL at 2 years of follow-up after adjusting for clinical variables. RESULTS In each treatment group, HRQL initially deteriorated after treatment with subsequent partial recovery. However, some dimension scores were still significantly lower after 2 years of treatment. The GEE models showed that, compared with the brachytherapy group, radical prostatectomy patients had worse EPIC sexual summary and urinary incontinence scores (-20.4 and -14.1; p < 0.001), and external radiotherapy patients had worse EPIC bowel, sexual, and hormonal summary scores (-3.55, -5.24, and -1.94; p < 0.05). Prostatectomy patients had significantly better EPIC urinary irritation scores than brachytherapy patients (+4.16; p < 0.001). CONCLUSIONS Relevant differences between treatment groups persisted after 2 years of follow-up. Radical prostatectomy had a considerable negative effect on sexual functioning and urinary continence. Three-dimensional conformal radiotherapy had a moderate negative impact on bowel functioning, and brachytherapy caused moderate urinary irritation. These results provide relevant information for clinical decision making.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D011468 Prostatectomy Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE). Prostatectomy, Retropubic,Prostatectomy, Suprapubic,Prostatectomies,Prostatectomies, Retropubic,Prostatectomies, Suprapubic,Retropubic Prostatectomies,Retropubic Prostatectomy,Suprapubic Prostatectomies,Suprapubic Prostatectomy
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D001918 Brachytherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Curietherapy,Implant Radiotherapy,Plaque Therapy, Radioisotope,Radioisotope Brachytherapy,Radiotherapy, Interstitial,Radiotherapy, Intracavity,Radiotherapy, Surface,Brachytherapy, Radioisotope,Interstitial Radiotherapy,Intracavity Radiotherapy,Radioisotope Plaque Therapy,Radiotherapy, Implant,Surface Radiotherapy,Therapy, Radioisotope Plaque
D006304 Health Status The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures. General Health,General Health Level,General Health Status,Level of Health,Overall Health,Overall Health Status,General Health Levels,Health Level,Health Level, General,Health Levels,Health Status, General,Health Status, Overall,Health, General,Health, Overall,Level, General Health,Levels, General Health,Status, General Health,Status, Health,Status, Overall Health

Related Publications

Montserrat Ferrer, and José Francisco Suárez, and Ferran Guedea, and Pablo Fernández, and Víctor Macías, and Alfonso Mariño, and Asunción Hervas, and Ismael Herruzo, and María José Ortiz, and Humberto Villavicencio, and Jordi Craven-Bratle, and Olatz Garin, and Ferran Aguiló, and
November 2001, International journal of radiation oncology, biology, physics,
Montserrat Ferrer, and José Francisco Suárez, and Ferran Guedea, and Pablo Fernández, and Víctor Macías, and Alfonso Mariño, and Asunción Hervas, and Ismael Herruzo, and María José Ortiz, and Humberto Villavicencio, and Jordi Craven-Bratle, and Olatz Garin, and Ferran Aguiló, and
January 2009, Scandinavian journal of urology and nephrology,
Montserrat Ferrer, and José Francisco Suárez, and Ferran Guedea, and Pablo Fernández, and Víctor Macías, and Alfonso Mariño, and Asunción Hervas, and Ismael Herruzo, and María José Ortiz, and Humberto Villavicencio, and Jordi Craven-Bratle, and Olatz Garin, and Ferran Aguiló, and
May 2013, Journal of the National Cancer Institute,
Montserrat Ferrer, and José Francisco Suárez, and Ferran Guedea, and Pablo Fernández, and Víctor Macías, and Alfonso Mariño, and Asunción Hervas, and Ismael Herruzo, and María José Ortiz, and Humberto Villavicencio, and Jordi Craven-Bratle, and Olatz Garin, and Ferran Aguiló, and
March 2014, Journal of the National Cancer Institute,
Montserrat Ferrer, and José Francisco Suárez, and Ferran Guedea, and Pablo Fernández, and Víctor Macías, and Alfonso Mariño, and Asunción Hervas, and Ismael Herruzo, and María José Ortiz, and Humberto Villavicencio, and Jordi Craven-Bratle, and Olatz Garin, and Ferran Aguiló, and
March 2014, Journal of the National Cancer Institute,
Montserrat Ferrer, and José Francisco Suárez, and Ferran Guedea, and Pablo Fernández, and Víctor Macías, and Alfonso Mariño, and Asunción Hervas, and Ismael Herruzo, and María José Ortiz, and Humberto Villavicencio, and Jordi Craven-Bratle, and Olatz Garin, and Ferran Aguiló, and
October 2013, The Journal of urology,
Montserrat Ferrer, and José Francisco Suárez, and Ferran Guedea, and Pablo Fernández, and Víctor Macías, and Alfonso Mariño, and Asunción Hervas, and Ismael Herruzo, and María José Ortiz, and Humberto Villavicencio, and Jordi Craven-Bratle, and Olatz Garin, and Ferran Aguiló, and
March 2001, Techniques in urology,
Montserrat Ferrer, and José Francisco Suárez, and Ferran Guedea, and Pablo Fernández, and Víctor Macías, and Alfonso Mariño, and Asunción Hervas, and Ismael Herruzo, and María José Ortiz, and Humberto Villavicencio, and Jordi Craven-Bratle, and Olatz Garin, and Ferran Aguiló, and
March 2016, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
Montserrat Ferrer, and José Francisco Suárez, and Ferran Guedea, and Pablo Fernández, and Víctor Macías, and Alfonso Mariño, and Asunción Hervas, and Ismael Herruzo, and María José Ortiz, and Humberto Villavicencio, and Jordi Craven-Bratle, and Olatz Garin, and Ferran Aguiló, and
September 1999, Urology,
Montserrat Ferrer, and José Francisco Suárez, and Ferran Guedea, and Pablo Fernández, and Víctor Macías, and Alfonso Mariño, and Asunción Hervas, and Ismael Herruzo, and María José Ortiz, and Humberto Villavicencio, and Jordi Craven-Bratle, and Olatz Garin, and Ferran Aguiló, and
January 2019, Frontiers in oncology,
Copied contents to your clipboard!